HUP9900751A3 - Stable pharmaceutical forms of administration containing parathormone - Google Patents

Stable pharmaceutical forms of administration containing parathormone

Info

Publication number
HUP9900751A3
HUP9900751A3 HU9900751A HUP9900751A HUP9900751A3 HU P9900751 A3 HUP9900751 A3 HU P9900751A3 HU 9900751 A HU9900751 A HU 9900751A HU P9900751 A HUP9900751 A HU P9900751A HU P9900751 A3 HUP9900751 A3 HU P9900751A3
Authority
HU
Hungary
Prior art keywords
parathormone
pharmaceutical forms
stable pharmaceutical
administration containing
administration
Prior art date
Application number
HU9900751A
Other languages
Hungarian (hu)
Original Assignee
Roche Diagnostics Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roche Diagnostics Gmbh filed Critical Roche Diagnostics Gmbh
Publication of HUP9900751A2 publication Critical patent/HUP9900751A2/en
Publication of HUP9900751A3 publication Critical patent/HUP9900751A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/29—Parathyroid hormone (parathormone); Parathyroid hormone-related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/18—Drugs for disorders of the endocrine system of the parathyroid hormones
HU9900751A 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone HUP9900751A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19538687A DE19538687A1 (en) 1995-10-17 1995-10-17 Stable pharmaceutical dosage forms containing parathyroid hormone

Publications (2)

Publication Number Publication Date
HUP9900751A2 HUP9900751A2 (en) 1999-07-28
HUP9900751A3 true HUP9900751A3 (en) 2000-07-28

Family

ID=7775105

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900751A HUP9900751A3 (en) 1995-10-17 1996-10-17 Stable pharmaceutical forms of administration containing parathormone

Country Status (14)

Country Link
EP (1) EP0855917A1 (en)
JP (1) JPH11515002A (en)
KR (1) KR19990064322A (en)
AU (1) AU7294196A (en)
BR (1) BR9610983A (en)
CA (1) CA2234724A1 (en)
CZ (1) CZ108398A3 (en)
DE (1) DE19538687A1 (en)
HU (1) HUP9900751A3 (en)
NZ (1) NZ320237A (en)
SK (1) SK47298A3 (en)
TR (1) TR199800690T1 (en)
WO (1) WO1997014429A1 (en)
ZA (1) ZA968715B (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19539574A1 (en) 1995-10-25 1997-04-30 Boehringer Mannheim Gmbh Preparations and processes for stabilizing biological materials by means of drying processes without freezing
DE19716154A1 (en) * 1997-04-18 1998-10-22 Boehringer Mannheim Gmbh Stable pharmaceutical dosage form for peptides, proteins and nucleic acids
US6770623B1 (en) * 1997-12-09 2004-08-03 Eli Lilly And Company Stabilized teriparatide solutions
ZA9811127B (en) † 1997-12-09 2000-07-11 Lilly Co Eli Stabilized teriparatide solutions.
SE9801495D0 (en) * 1998-04-28 1998-04-28 Astra Ab Protein formulation
WO2001032201A2 (en) * 1999-10-29 2001-05-10 Eli Lilly And Company A pharmaceutical composition having high cell membrane permeability
EP1586329A1 (en) * 2000-02-08 2005-10-19 Allergan, Inc. Botulinum toxin pharmaceutical compositions
MY136546A (en) 2000-06-30 2008-10-31 Asubio Pharma Co Ltd A pharmaceutical component based on human parathyroid harmone and a pharmaceutical composition for intranasal administration comprising the component
JP4607010B2 (en) * 2003-02-28 2011-01-05 中外製薬株式会社 Protein-containing stabilized preparation
WO2005014034A1 (en) * 2003-07-14 2005-02-17 Nps Allelix Corp. Stabilized formulation of parathyroid hormone
KR100700869B1 (en) * 2005-06-03 2007-03-29 재단법인 목암생명공학연구소 The stabilized parathyroid hormone composition comprising parathyroid hormone buffer and stabilizing agent
USRE49444E1 (en) 2006-10-03 2023-03-07 Radius Health, Inc. Method of treating osteoporosis comprising administration of PTHrP analog
FR2947181B1 (en) * 2009-06-26 2012-05-04 Lfb Biotechnologies FACTOR VII COMPOSITION
KR101891673B1 (en) 2011-06-07 2018-08-27 아사히 가세이 파마 가부시키가이샤 Freeze-dried preparation containing high-purity pth and method for producing same
CN113750091A (en) 2015-04-29 2021-12-07 雷迪厄斯制药公司 Methods for treating cancer
JP6634758B2 (en) * 2015-09-25 2020-01-22 ニプロ株式会社 Liquid composition and freeze-dried preparation
KR102322802B1 (en) 2017-01-05 2021-11-04 래디어스 파마슈티컬스, 인코포레이티드 Polymorphic form of RAD1901-2HCL
US10996208B2 (en) 2017-04-28 2021-05-04 Radius Health, Inc. Abaloparatide formulations and methods of testing, storing, modifying, and using same
JP6577683B2 (en) * 2017-09-22 2019-09-18 旭化成ファーマ株式会社 Liquid pharmaceutical composition containing teriparatide having excellent stability
WO2020010216A1 (en) 2018-07-04 2020-01-09 Radius Pharmaceuticals, Inc. Polymorphic forms of rad 1901-2hcl
WO2021229835A1 (en) * 2020-05-11 2021-11-18 旭化成ファーマ株式会社 Stable liquid pharmaceutical preparation containing teriparatide or salt thereof
JP6947946B1 (en) * 2020-05-11 2021-10-13 旭化成ファーマ株式会社 Stable liquid pharmaceutical product containing teriparatide or a salt thereof

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816568A (en) * 1986-05-16 1989-03-28 International Minerals & Chemical Corp. Stabilization of growth hormones
JP2739482B2 (en) * 1988-08-11 1998-04-15 バイオ・チバ株式会社 Method for producing stable calcitonin injection
JPH0341033A (en) * 1989-07-07 1991-02-21 Kyowa Hakko Kogyo Co Ltd Stable preparation containing motilins
KR0131678B1 (en) * 1991-12-09 1998-04-17 유미꾸라 레이이찌 Stabilized parathyroid hormone composition
DE4203040A1 (en) * 1992-02-04 1993-08-05 Boehringer Mannheim Gmbh NEW PARATHORMON FRAGMENTS, THEIR PRODUCTION AND MEDICINAL PRODUCTS CONTAINING THEM

Also Published As

Publication number Publication date
TR199800690T1 (en) 1998-06-22
WO1997014429A1 (en) 1997-04-24
BR9610983A (en) 1999-03-02
NZ320237A (en) 1999-11-29
AU7294196A (en) 1997-05-07
ZA968715B (en) 1998-04-16
CZ108398A3 (en) 1998-09-16
EP0855917A1 (en) 1998-08-05
DE19538687A1 (en) 1997-04-24
JPH11515002A (en) 1999-12-21
CA2234724A1 (en) 1997-04-24
SK47298A3 (en) 1998-11-04
KR19990064322A (en) 1999-07-26
HUP9900751A2 (en) 1999-07-28

Similar Documents

Publication Publication Date Title
HUP9900751A3 (en) Stable pharmaceutical forms of administration containing parathormone
HRP960300B1 (en) Inhaler for administration of blister-packed medicaments
IL117265A (en) Benzazepine- benzoxazepine- and benzothiazepine-N-acetic acid derivatives their preparation and pharmaceutical compositions containing them
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
IL116851A (en) 3-arylidene-2-oxindole derivatives and pharmaceutical compositions containing them
PL312064A1 (en) Soft gelatinous form of pharmaceutical dose
IL117193A0 (en) Poly-pyrrolecarbox-amidenaphthalenic acid derivatives their preparation and pharmaceutical compositions containing them
IL117041A0 (en) Oral pharmaceutical dosage form
HK1043042A1 (en) Pharmaceutical formulation containing amoxycillin and clavulanate
AP9701160A0 (en) Compounds and pharmaceutical compositions containing them
IL119559A0 (en) Purin -6- one derivatives their preparation and pharmaceutical compositions containing them
HUP9801749A3 (en) Nodulisporic acid derivatives and pharmaceutical compositions containing them
IL115125A0 (en) Pharmaceutical formulations comprising derivatives of clavulanic acid
AU1766592A (en) Pharmaceutical formulations of a benzodiazepine
GB9601186D0 (en) Administration of Drugs
HU9500386D0 (en) Benzodiazepine derivatives and pharmaceutical compositions containing them
ZA964517B (en) Oral pharmaceutical composition of piperidinoalkanol compounds in solution form
IL116910A0 (en) Novel pharmaceutical formulation for topical administration
HUP9802291A3 (en) Penicillaminamide derivatives and pharmaceutical compositions containing them
IL117152A0 (en) Substituted benzenesulfonylureas and -thioureas processes for their preparation and use of pharmaceutical preparation based on these compounds and medicaments containing them
IL123000A (en) Aza-anthracylinone derivatives their preparation and pharmaceutical compositions containing them
AU5560694A (en) Pharmaceutical formulations of ibuprofen
GB9304745D0 (en) Use of pharmaceutical formulations
IL122652A (en) Polymorphs of the pro drug 6-n-(l-ala-l-ala)- trovafloxacin their preparation and pharmaceutical compositions containing them
GB9304549D0 (en) Apparatus for administration of drugs